Login / Signup

Evaluating the primary care clinical pharmacist visit transition to telehealth during the COVID-19 pandemic by comparing medication related problems from telehealth visits and in-person visits.

Anusha McNamaraMilly ZhaoShin-Yu Lee
Published in: Journal of the American College of Clinical Pharmacy : JACCP (2021)
These results provide a start to establish criteria for which patients should be seen by a clinical pharmacist in person vs over the phone.
Keyphrases
  • primary care
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • mental health
  • patient reported outcomes
  • patient reported
  • adverse drug